Elliott M. Antman, MD, FACC
Dr. Antman is director of the Samuel A. Levine Cardiac Unit in the Cardiovascular Division of the Brigham and Women's Hospital in Boston, Massachusetts.
Read More
Arthur Kavanaugh, MD
Dr. Kavanaugh is Professor of Medicine at The University of California at San Diego, School of Medicine and the Director of the Center for Innovative Therapy in Division of Rheumatology, Allergy and Immunology.
Read More
Lawrence Rice, MD
Dr. Lawrence Rice is Professor of Medicine in Hematology and Thrombosis Research. He has been Program Director of Hematology...
Read More
Hatim Omar, MD, FAAP
Dr. Omar is a Professor in Pediatrics and Obstetrics Gynecology and Director of Adolescent Medicine and Young Parent Program at the University of Kentucky in Lexington, Kentucky.
Read More
End-stage renal disease (ESRD) requiring renal replacement therapy or kidney transplantation is the final consequence of chronic kidney disease (CKD). CKD has emerged as an important public health concern with the recognition of the dramatic association of CKD and cardiovascular disease (CVD). Among patients with early CKD, the risk of death (likely from CVD) is much greater than the risk of progressing to ESRD. Even among patients with stage 4 CKD, the risk of death (again, likely from...
Read More
The trend to minimize the use of calcineurin inhibitors (CNIs) and corticosteroids (CSs) has contributed to an increase in the use of antibody induction therapy in kidney and liver transplantation. Significant comorbid conditions associated with historical maintenance immunosuppressive regimens consisting of CNIs and CSs have resulted in a paradigm shift in clinical practice. Identification of immunosuppressive regimens that both reduce long-term immunosuppressive load, and minimize...
Read More
